This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pentimalli, F. Articles by Fusco, A. Search for Related Content PubMed PubMed Citation Articles by Pentimalli, F. Articles by Fusco, A.

Suppression of HMGA2 Protein Synthesis Could Be a Tool for the Therapy of Well Differentiated Liposarcomas Overexpressing HMGA2¹

Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli, 80131 Naples, Italy [F. P., M. D., M. F., G. M. P., L. C., P. P., M. S., G. V., A. F.], and Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts 02115-6195 [P. D. C.]

Atypical lipomatous tumors (ALTs)/well-differentiated liposarcomas represent a distinctive subset of mesenchymal neoplasms featuring mature adipocytic proliferation. These tumors are characterized cytogenetically by the presence of supernumerary ring and/or long marker chromosomes that contain several copies of the chromosomal region 12q13–15, in which the HMGA2 gene is located. Deregulation of the HMGA2 gene is a common molecular alteration implicated in the development of a variety of benign tumors, such as lipomas, uterine leiomyomas, and pulmonary chondroid hamartomas. In this study, we observed HMGA2 overexpression in 7 of 12 ALT primary cell cultures examined. Subsequently, we generated an adenovirus containing the HMGA2 gene in the antisense orientation (Ad-A2as) to study the effect of HMGA2 protein suppression in ALT cells. The infection of six ALT cells, three of which were positive for HMGA2 expression, resulted in growth inhibition coupled with a significant increase in apoptosis. In addition, the growth of the ALT cells negative for HMGA2 expression was not affected by the infection with either the Ad-A2as or the control virus. On the basis of these findings, the targeting of the HMGA2 protein expression may represent a promising approach for treating the well-differentiated liposarcomas resistant to conventional therapies.

This article has been cited by other articles:

				F. Di Cello, J. Hillion, A. Hristov, L. J. Wood, M. Mukherjee, A. Schuldenfrei, J. Kowalski, R. Bhattacharya, R. Ashfaq, and L. M.S. Resar HMGA2 Participates in Transformation in Human Lung Cancer Mol. Cancer Res., May 1, 2008; 6(5): 743 - 750. [Abstract] [Full Text] [PDF]

				B. Boyerinas, S.-M. Park, N. Shomron, M. M. Hedegaard, J. Vinther, J. S. Andersen, C. Feig, J. Xu, C. B. Burge, and M. E. Peter Identification of Let-7-Regulated Oncofetal Genes Cancer Res., April 15, 2008; 68(8): 2587 - 2591. [Abstract] [Full Text] [PDF]

				I. Cleynen, J. R. Brants, K. Peeters, R. Deckers, M. Debiec-Rychter, R. Sciot, W. J.M. Van de Ven, and M. M.R. Petit HMGA2 Regulates Transcription of the Imp2 Gene via an Intronic Regulatory Element in Cooperation with Nuclear Factor-{kappa}B Mol. Cancer Res., April 1, 2007; 5(4): 363 - 372. [Abstract] [Full Text] [PDF]